Our Vision
To substantially and equitably mitigate harms from substance use regionally and nationally.
header-wave
Narcan Distributed in 2023
Narcan Distributed in 2024
Narcan Distributed in 2025

Clinical

  • Medications for Opioid Use Disorder (MOUD)

    Yes, we have effective medications: Read more about buprenorphine, methadone and naltrexone.

     

Education

What is an “X Waiver” and who needs one?

This legal waiver is no longer required for a clinician to prescribe the lifesaving medication buprenorphine. A major shift in policy allows any DEA registered provider to prescribe the drug going forward.

Receive CPE Credit for Attending our Virtual Webinar

Low-barrier care is essential to support our patients. CPE credit available for pharmacists/pharmacy students

Narcan

Narcan is a highly effective antidote to opioid overdose: Learn how to use it!

Research

Implementation in Practice

Check out our new clinical trial at the Penn Presbyterian ED to help start patients on the medication buprenorphine.

Research in the News

Read about our program in our “playbook” for other EDs to start an ED buprenorphine program.

News

Study finds access to lifesaving medication for opioid addiction in Philadelphia remains uneven

March 2025
WHYY

Devin’s Sunshine Story: Here Through It All

October 2024

‘This isn’t about policy’: Vigil honors overdose victims in McPherson Square Park despite disruption from Philly police

August 2024

Implementation of an ED Buprenorphine Program

In 3 urban academic emergency departments (EDs), a onetime incentive for X-waiver training was offered.

Success Rates

83
(56,63)
Overall, 89% of eligible emergency physicians completed the X-waiver training during the 6-week incentive period.
Buprenorphine prescribing rates increased to 15% (from <1%) during the first 4 months of the program.
This study shows how enthusiastically emergency physicians embraced the opportunity to obtain this certification, which speaks to the shifting national conversation surrounding opioid use disorder," said Sean Foster, MD. "This also gives a 'playbook' to any leaders and administrators who may be looking for ways to get their group trained."
After the incentive, buprenorphine prescribing per OUD encounter increased from 0.5% to 16%.
Data comes from Providing Incentive for Emergency Physician X-Waiver Training: An Evaluation of Program Success and Postintervention Buprenorphine Prescribing https://www.annemergmed.com/article/S0196-0644(20)30140-2/pdf